These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 6210244)
1. [Lymphokine production in vitro by blood lymphocytes from patients with a defective or hyperactive immune system]. Gronewold P; Northoff H; Kirchner H; Peter HH Immun Infekt; 1984 Nov; 12(6):287-97. PubMed ID: 6210244 [TBL] [Abstract][Full Text] [Related]
2. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones. Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470 [TBL] [Abstract][Full Text] [Related]
4. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction. Suzuki R; Suzuki S; Igarashi M; Kumagai K J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574 [TBL] [Abstract][Full Text] [Related]
5. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients. Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162 [TBL] [Abstract][Full Text] [Related]
6. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. Sneller MC; Strober W J Immunol; 1990 May; 144(10):3762-9. PubMed ID: 2110212 [TBL] [Abstract][Full Text] [Related]
7. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes. Conlon KC; Ochoa AC; Kopp WC; Ortaldo JR; Urba WJ; Longo DL; Young HA J Immunol; 1992 Nov; 149(10):3278-89. PubMed ID: 1358968 [TBL] [Abstract][Full Text] [Related]
8. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome. Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development. Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones. Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456 [TBL] [Abstract][Full Text] [Related]
11. Characterization of human cytotoxic lymphocytes directed against cells infected with typhus group rickettsiae: evidence for lymphokine activation of effectors. Carl M; Dasch GA J Immunol; 1986 Apr; 136(7):2654-61. PubMed ID: 3081648 [TBL] [Abstract][Full Text] [Related]
12. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons. Amento EP; Kurnick JT; Krane SM J Immunol; 1985 Jan; 134(1):350-7. PubMed ID: 2578047 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells. Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298 [TBL] [Abstract][Full Text] [Related]
15. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of the functional activity of lymphokine-activated killer cells in healthy donors and in patients with interleukin-2-dependent immunodeficiency]. Petrov RV; Koval'chuk LV; Kalinina AR; Pavliuk AS; Ul'ianova TIu Biull Eksp Biol Med; 1989 Jun; 107(6):713-5. PubMed ID: 2790170 [TBL] [Abstract][Full Text] [Related]
17. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013 [TBL] [Abstract][Full Text] [Related]
18. Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Yan S; Marguet D; Dobers J; Reutter W; Fan H Eur J Immunol; 2003 Jun; 33(6):1519-27. PubMed ID: 12778469 [TBL] [Abstract][Full Text] [Related]
19. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis. Sato MN; Minoprio P; Avrameas S; Ternynck T Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519 [TBL] [Abstract][Full Text] [Related]
20. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF). Pisko EJ; Foster SL; White RE; Panetti M; Turner RA J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]